CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,953,260
- in 5 filings, $6.0M under 10b5-1 plans
Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-24 | Madaus Martin D Director | Other acquisition | +11 | $186.22 | $2K | 11 |
| 2023-03-03 | Snodgres Jon Chief Financial Officer | Grant or award | +8,795 | 41,765 | ||
| 2023-03-03 | Snodgres Jon Chief Financial Officer | Shares withheld for taxes | −3,674 | $188.00 | $691K | 38,091 |
| 2023-03-03 | KURIYEL RALF Senior VP, R&D | Grant or award | +3,591 | 25,513 | ||
| 2023-03-03 | KURIYEL RALF Senior VP, R&D | Shares withheld for taxes | −1,247 | $188.00 | $234K | 24,266 |
| 2023-03-03 | Gebski Christine See Remarks | Grant or award | +375 | 33,035 | ||
| 2023-03-03 | Gebski Christine See Remarks | Shares withheld for taxes | −126 | $188.00 | $24K | 32,909 |
| 2023-03-03 | Hunt Anthony Chief Executive Officer | Grant or award | +18,584 | 203,551 | ||
| 2023-03-03 | Hunt Anthony Chief Executive Officer | Shares withheld for taxes | −8,244 | $188.00 | $1.5M | 195,307 |
| 2023-03-03 | Bylund James Chief Operating Officer | Grant or award | +625 | 18,112 | ||
| 2023-03-03 | Bylund James Chief Operating Officer | Shares withheld for taxes | −210 | $188.00 | $39K | 17,902 |
| 2023-03-02 | Snodgres Jon Chief Financial Officer | Grant or award | +4,848 | 32,970 | ||
| 2023-03-02 | Snodgres Jon Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +5,019 | 5,019 | ||
| 2023-03-02 | KURIYEL RALF Senior VP, R&D | Grant or award | +3,468 | 21,922 | ||
| 2023-03-02 | KURIYEL RALF Senior VP, R&D | Grant or award · Stock Option (Right to Buy) | +3,591 | 3,591 | ||
| 2023-03-02 | Gebski Christine See Remarks | Grant or award | +3,467 | 32,660 | ||
| 2023-03-02 | Gebski Christine See Remarks | Grant or award · Stock Option (Right to Buy) | +3,590 | 3,590 | ||
| 2023-03-02 | Hunt Anthony Chief Executive Officer | Grant or award | +19,393 | 184,967 | ||
| 2023-03-02 | Hunt Anthony Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +20,080 | 20,080 | ||
| 2023-03-02 | Bylund James Chief Operating Officer | Grant or award | +8,348 | 17,487 |
Page 16 of 23 · 455 trades